CNY 26.34
−9.98%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 26.25
From 52W high−36.68%
Volume3.45M
Market capCNY 23.39B
P/E (TTM)11.6x
P/S (TTM)2.0x
Div yield5.45%
Key dataSep 18, 2026
Open
CNY 26.25
From 52W high
−36.68%
Volume
3.45M
Market cap
CNY 23.39B
ValuationView details →
P/E (Fwd)
26.0x
EV/EBITDA
5.2x
P/E (TTM)
11.6x
RSI (14)
35.0
MomentumView details →
1D Return
−9.98%
YTD Return
−23.88%
Similar companies
Latest newsMore news →
Livzon Pharmaceutical Group announced a special interim dividend of RMB 1.02 per share, totaling over RMB 905 million, approved by its board on September 8, 2026.12d agoLivzon Pharmaceutical Group announced that its controlling subsidiary Livzon Mab received a drug registration certificate from China's National Medical Products Administration for the subcutaneous injection of Lekankitamab (Libaitan), a Class 1 therapeutic biologic approved for treating adult patients with moderate-to-severe plaque psoriasis.24d ago